Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rebecca Kirk
Observed names:
Kirk, Rebecca,
Rebecca A. Kirk
Institutions:
Plant & Food Research,
Bioeconomy Science Institute
Observed institutions:
Public Library of Science,
Plant & Food Research,
Research Institute of Molecular Pathology,
Cancer Research UK,
Thomson Reuters (United Kingdom),
Bioeconomy Science Institute
show all 6
ORCID:
0000-0003-3541-0168
Observed ORCID:
0000-0003-3541-0168
OpenAlex ID:
A5055182829
High drug attrition rates—where are we going wrong?
2011
·
Lisa Hutchinson
, Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
530
PDF
Structural adaptation of the plant protease Deg1 to repair photosystem II during light exposure
2011
·
Juliane Kley
, Bastian Schmidt
, et al.
·
Nature Structural & Molecular Biology
·
96
Structure of a Conserved Dimerization Domain within the F-box Protein Fbxo7 and the PI31 Proteasome Inhibitor
2008
·
Rebecca Kirk
, Heike Laman
, et al.
·
Journal of Biological Chemistry
·
88
PDF
Regulation of the σE stress response by DegS: how the PDZ domain keeps the protease inactive in the resting state and allows integration of different OMP-derived stress signals upon folding stress
2007
·
Hanna Hasselblatt
, Robert Kurzbauer
, et al.
·
Genes & Development
·
88
PDF
Personalized medicine and tumour heterogeneity
2012
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
23
KIM-1 expression links kidney injury with CKD in mice
2013
·
Rebecca Kirk
·
Nature Reviews Nephrology
·
12
In colorectal cancer, not all KRAS mutations are created equal
2010
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
11
Evidence points to the existence of cancer stem cells
2012
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
10
Oncology trials—the elephant in the room
2012
·
Rebecca Kirk
, Lisa Hutchinson
·
Nature Reviews Clinical Oncology
·
9
PDF
CD8+:FOXP3+ cell ratio is a novel survival marker for colorectal cancer
2010
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
9
The toxic reality of new drugs
2012
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
8
Bevacizumab and heart failure
2011
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
7
Oncotype DX® assay predicts local recurrence in breast cancer
2010
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
7
New classification for endometrial cancer puts genes in POLE position
2013
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
6
STAT3 and EGFR target resistance
2012
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
6
A first for first-line therapy in NSCLC
2011
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
6
Clinical trials in CNS--SMi's eighth annual conference.
2010
·
Rebecca Kirk
·
PubMed
·
6
Hit the lymphoma, JAK
2012
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
5
Cancer risk reduction in BRCA mutation carriers
2010
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
5
Supporting Research and Education Stakeholders in Meeting the Sustainable Development Goals Through the HESI SDG Publishers Compact Fellows
2024
·
Derek M. Lough
, Rebecca Kirk
, et al.
·
World sustainability series
·
4
Negative feedback loop reveals novel potential therapy
2013
·
Rebecca Kirk
·
Nature Reviews Nephrology
·
4
The maths behind combination therapy
2013
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
4
Adoptive cell therapy simplified
2013
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
4
New paradigms to explain metastasis
2011
·
Lisa Hutchinson
, Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
4
PDF
New standard of therapy for HER2-positive gastric cancers?
2010
·
Rebecca Kirk
·
Nature Reviews Clinical Oncology
·
4
Show more works
View as search
Works count:
117
Citation count:
1,028
H-index:
9
I10-index:
8
Year
Topic
Type
